Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
NYU Langone Health
Dana-Farber Cancer Institute
University of Florida
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University Hospital, Grenoble
Roswell Park Cancer Institute
Gruppo Oncologico del Nord-Ovest
Stanford University
University of Pittsburgh
University of Minnesota
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Mirror Biologics, Inc.
Northwestern University
Children's Hospital Medical Center, Cincinnati
AIM ImmunoTech Inc.
Ability Pharmaceuticals SL
Metabiomics Corp
Center Eugene Marquis
University Hospital, Bordeaux
ProgenaBiome
Weill Medical College of Cornell University
NextPoint Therapeutics, Inc.
Fudan University
Cancer Research UK
Primocure Pharma
Coordinación de Investigación en Salud, Mexico
UNICANCER
Xijing Hospital of Digestive Diseases
Ohio State University Comprehensive Cancer Center
UMC Utrecht
The Clatterbridge Cancer Centre NHS Foundation Trust
Adlai Nortye Biopharma Co., Ltd.
Oslo University Hospital
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Zhejiang Cancer Hospital
Universita di Verona
DNAtrix, Inc.
Obafemi Awolowo University Teaching Hospital
Universitätsklinikum Hamburg-Eppendorf
Shanghai Minimally Invasive Surgery Center
The Christie NHS Foundation Trust
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Tenwek Hospital